The IAS–USA Annual Virtual Course Update: Emerging Challenges in HIV Medicine (On-Demand)

Program Description

This enduring on-demand half-day virtual course explored emerging challenges in HIV medicine. This course delved into difficult cases in antiretroviral therapy, including the implementation of long-acting drugs. The course also addressed key issues in HIV prevention, such as postexposure prophylaxis (PEP) for sexual and occupational exposures, and the future of HIV vaccines in the context of emerging long-acting agents. Other key topics include updates on sexually transmitted infections (STIs), including the use of doxycycline postexposure prophylaxis (doxy-PEP), antimicrobial resistance trends, and national penicillin shortages, and highlights of recent data and guideline changes presented at major scientific conferences.

Assessment of Needs

Rapid advances in HIV disease management require the ongoing attention of practitioners involved in direct patient care. This course will address the implications of new information on strategies for the clinical management of HIV and other emerging challenges in HIV medicine. Information will be presented through a mix of didactic lectures, clinically relevant cases, and discussions developed and led by an expert faculty of HIV/AIDS clinicians and researchers.

Learning Objectives

After participating in the activity, learners will be able to:

• Implement the latest recommendations for initiating and changing antiretroviral therapy in clinical circumstances such as comorbid conditions, coinfections, pregnancy, and geriatric syndromes
• Describe the most current data from recent scientific conferences, including research on new and investigational antiretroviral drugs
• Describe best practices for PEP following sexual and occupational exposures, including differences in follow-up protocols and vaccination considerations
• Assess the evolving role of HIV vaccines, including current research directions and the need for vaccines in the context of long-acting prevention strategies
• Describe the latest evidence-based treatment guidelines for common STIs, including clinical implications and antimicrobial resistance trends

Preliminary Topics

• Difficult cases in antiretroviral therapy
• PEP for sexual and occupational (ie, healthcare worker) exposures
• HIV vaccines in 2026 and beyond
• Emerging issues in STIs, including doxy-PEP, antimicrobial resistance, and drug shortages
• “In Case You Missed It” overview of recent conference data, guidelines, and publications

Conflicts of Interest

In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.  

The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.” 

IAS–USA has identified and mitigated ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenter and planners/reviewers is below and in the slides prior to the presentation of educational content.

Registration

Who Should Attend

This course is designed for physicians who are actively involved in the medical care of people with HIV infection and:

• Have a solid, working knowledge of HIV disease management
• Provide comprehensive or specialty care for patients with HIV infection
• Are currently active in HIV research

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

Please note: if you already have participated on the live course and have received CME credits, you will not receive additional credits from this activity.